Cross-sectional and prospective association between proinsulin secretion and graft function after clinical islet transplantation

Transplantation

Volumn 78, Issue 6, 2004, Pages 934-937

  McDonald, Charlotte G ^a   Ryan, Edmond A ^a   Paty, Breay W ^a   Senior, Peter A ^a   Marshall, Sally M ^b   Lakey, Jonathan R T ^a   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Clinical transplantation; Insulin; Islets; Proinsulin; Type 1 diabetes

Indexed keywords

C PEPTIDE; INSULIN; PROINSULIN;

ALLOTRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FASTING; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; PROINSULIN; REFERENCE VALUES; TIME FACTORS;

EID: 4644260412     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000134973.77057.39     Document Type: Article

References (18)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
2. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148-2157.
3. Rhodes CJ, Halban PA. Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol 1987; 105: 145-153.
4. Larsson H, Ahren B. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J Clin Endocrinol Metab 1999; 84: 2068-2074.
5. Roder ME, Porte D Jr., Schwartz RS, et al. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 604-608.
6. Kahn SE, Halban PA. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 1997; 46: 1725-1732.
7. Lindgren FA, Hartling SG, Dahlquist GG, et al. Glucose-induced insulin response is reduced and proinsulin response increased in healthy siblings of type 1 diabetic patients. Diabet Med 1991; 8: 638-643.
8. Haffher SM, Gonzalez C, Mykkanen L, et al. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997; 40: 830-837.
9. Seaquist ER, Kahn SE, Clark PM, et al. Hyperproinsulinemia is associated with increased beta cell demand after hemipancreatectomy in humans. J Clin Invest 1996; 97: 455-460.
10. Christiansen E, Roder M, Tibell A, et al. Effect of pancreas transplantation and immunosuppression on proinsulin secretion. Diabet Med 1998; 15: 739-746.
11. Osei K, Henry ML, O'Dorisio TM, et al. Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes 1990; 39: 1235-1242.
12. Babazono T, Teraoka S, Tomonaga O, et al. Circulating proinsulin levels in insulin-dependent diabetic patients after whole pancreas-kidney transplantation. Metabolism 1998; 47: 1325-1330.
13. White SA, Koppiker NP, Burden AC, et al. Insulin deficiency and increased intact and 32/33 split proinsulin secretion following human islet autotransplantation. Transplant Proc 1998; 30: 627-628.
14. Kahn SE, Horber FF, Prigeon RL, et al. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes 1993; 42: 1082-1085.
15. Fuhrer DK, Kobayashi M, Jiang H. Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 2001; 3: 393-402.
16. Kneteman NM, Lakey JR, Wagner T, et al. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 1996; 61: 1206-1210.
17. Bertuzzi F, Grohovaz F, Maffi P, et al. Successful [correction of Succesful] transplantation of human islets in recipients bearing a kidney graft. Diabetologia 2002; 45: 77-84.
18. White SA, Pollard C, Davies JE, et al. Temporal relationship of insulin, intact proinsulin and split proinsulin after islet autotransplantation. Transplant Proc 2001; 33: 680.